Mobile Cardiac Outpatient Telemetry denials in California external review
In the California DMHC record, independent physician reviewers decided 15 published external-review cases involving Mobile Cardiac Outpatient Telemetryand overturned the plan’s denial in 20%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Conditions behind Mobile Cardiac Outpatient Telemetry denials
| Category | Decisions | Overturned |
|---|---|---|
| Arrhythmia | 4 | 0% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 12 | 16.7% |
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 3 | 33.3% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for mobile cardiac outpatient telemetry. Mobile cardiac outpatient telemetry (MCOT) has emerged as a standard tool in the evaluation of patients with suspected cardiac arrhythmia. While traditional Holter monitors provide continuous electrocardiogram (ECG) monitoring, this modality is generally only available for 24 to 48 hours. Current MCOT systems with advanced technology permit nearly continuous, automatic, and, with some systems, real-time monitoring. These systems are often smaller and less intrusive to patients, leveraging patch-style devices rather than cumbersome, multi-lead systems.
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for wearable mobile cardiovascular telemetry services. This high-risk patient was hospitalized for sudden onset chest pain, focal unilateral numbness, and palpitations. The selection of appropriate technology for heart rhythm monitoring is based on factors including diagnostic power, risk stratification accuracy, patient acceptance, degree of automaticity, local availability, symptom frequency, overall clinical condition, and probability of life-threatening arrhythmia. In one study that evaluated patients who underwent outpatient electrocardiogram (ECG) monitoring, the authors concluded that diagnostic yield and anti-arrhythmic therapy initiation rates were both significantly higher in patients who underwent mobile cardiac outpatient telemetry (MCOT) compared to event monitors or Holter monitors.
Where the denial was upheld
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for mobile cardiac outpatient telemetry (MCOT) services. Non-real time (off-line) monitoring devices such as extended (48-hour) Holter monitoring or off-line event monitoring should have been sufficient for the identification of both symptomatic and asymptomatic dysrhythmias. There is a lack of documentation indicating that the patient was not able to effectively manage standard monitoring devices to evaluate the patient’s condition during the time period under review. Current expert consensus guidelines consider patient-activated event recorders and other off-line monitoring devices appropriate initial tests for the evaluation of supraventricular dysrhythmias including atrial fibrillation.
Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement for mobile cardiac outpatient telemetry (MCOT) services. Non-real time (off-line) monitoring devices such as extended (48-hour) Holter monitoring or off-line event monitoring should have been sufficient for the identification of both symptomatic and asymptomatic dysrhythmias. There is a lack of documentation indicating that the patient was not able to effectively manage standard monitoring devices to evaluate the patient’s condition during the time period under review. Current expert consensus guidelines consider patient-activated event recorders and other off-line monitoring devices appropriate initial tests for the evaluation of dysrhythmias.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Mobile Cardiac Outpatient Telemetry, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY